Corticotropin-releasing hormone augments natural killer cell activity through a naloxone-sensitive pathway.

Abstract excerpt

Overnight treatment of murine leukocytes with corticotropin-releasing hormone (CRH) and arginine vasopressin enhances natural killer cell activity. Moreover, the opioid receptor antagonist, naloxone, as well as the delta-class opioid receptor antagonist, naltrindole, can block this effect. The responsivity of murine leukocytes to CRH is both dose- and time-dependent. The effector cells are both MAC-1 and Thy-1.2...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to In Vitro Techniques
• Share to Killer Cells, Natural